CANGRELOR for Stent placement: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where CANGRELOR was used for Stent placement.
Most Reported Side Effects for CANGRELOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 144 | 44.6% | 25 | 9 |
| Vascular stent thrombosis | 29 | 9.0% | 4 | 1 |
| Drug ineffective | 26 | 8.1% | 3 | 13 |
| Haemorrhage | 22 | 6.8% | 6 | 5 |
| Death | 19 | 5.9% | 19 | 0 |
| No adverse event | 19 | 5.9% | 0 | 0 |
| Inappropriate schedule of product administration | 18 | 5.6% | 5 | 3 |
| Cardiac arrest | 15 | 4.6% | 8 | 0 |
| Cardiogenic shock | 14 | 4.3% | 11 | 3 |
| Gastrointestinal haemorrhage | 12 | 3.7% | 2 | 6 |
| Intentional product use issue | 11 | 3.4% | 1 | 1 |
| Drug ineffective for unapproved indication | 9 | 2.8% | 2 | 0 |
| Dyspnoea | 9 | 2.8% | 1 | 0 |
| Haemorrhage intracranial | 9 | 2.8% | 3 | 2 |
| Vascular access site haemorrhage | 9 | 2.8% | 3 | 1 |
Other Indications for CANGRELOR
Percutaneous coronary intervention (94)
Product used for unknown indication (83)
Off label use (81)
Antiplatelet therapy (41)
Acute myocardial infarction (17)
Thrombosis prophylaxis (12)
Anticoagulant therapy (10)
Coronary artery bypass (6)
Other Drugs Used for Stent placement
TICAGRELOR (3,424)
CLOPIDOGREL BISULFATE (1,909)
PRASUGREL (1,414)
ASPIRIN (407)
RIVAROXABAN (158)
EVOLOCUMAB (86)
METOPROLOL (80)
BRILINTA (79)
APIXABAN (73)
PLAVIX (68)